Could a substance from the jasmine flower hold the key to an effective new therapy to treat cancer? Prof. Eliezer Flescher of The Sackler Faculty of Medicine, Tel Aviv University thinks so. He and his colleagues have developed an anti-cancer drug based on a decade of research into the commercial applications of the compound Jasmonate, a synthetic compound derived from the flower itself. Prof. Flescher began to research the compound about a decade ago, and with his recent development of the drug, his studies have now begun to bear meaningful fruit.
"Acetylsalicylic acid (aspirin) is based on a plant stress hormone," says Prof. Flescher. "I asked myself, 'Could there be other plant stress hormones that have clinical efficacy?' While various studies have suggested that aspirin can prevent cancer, especially colon cancer, I realized that there could be a chance to find a potent plant hormone that could fight cancer even better. I pinpointed jasmonate."
Both blood cancers and solid tumors seem to be responsive to the jasmonate compound, known also as methyl jasmonate. Prof. Flescher refers to it as the "jasmonate scaffold," a basis for developing a series of chemical derivatives. In terms of bioavailability and safety, early first-in-man studies have proven successful, and Prof. Flescher is hopeful that an anti-cancer drug based on jasmonate could be on the shelf in America within four years through the activity of Sepal-Pharma which licensed his research from Ramot, the technology transfer arm of Tel Aviv University.
Normally drug development takes much longer. "The jasmonate compound is used widely in agriculture and in cosmetics," says Prof. Flescher. "Proven to be non-toxic, it has the same regulatory status as table salt. That and the fact we are working on a natural chemical gives us a good starting point for launching a new drug."
Other research groups are taking notice. Since Prof. Flescher started publishing papers on jasmonate (most recently in the academic journal Oncogene), six new research groups around the world have initiated research on the subject.
Peer commentary in Oncogene is positive about Prof. Flescher's promising research. "Methyl jasmonate," says the commentary, "has already been shown to have selective anticancer activity in preclinical studies, and this finding may stimulate the development of a novel class of small anticancer compounds."
Source: American Friends of Tel Aviv University
Related stories:
Formula discovered for longer plant life
(PhysOrg.com) -- Plants that grow more slowly stay fresh longer. In their study now published in PLoS Biology, scientists at the Max Planck Institute for Developmental Biology in Tübingen have shown that certain small sections of genes, so-called microRNAs, coordinate growth and aging processes in plants.
Small helpers in the genome coordinate defence strategies in plants
Not only are ribonucleic acids (RNA) active as transmitters of genetic information between DNA and proteins, but they also have an impact on gene expression in the form of small segments, 18-26 nucleotides long. These nucleic acids, called small RNAs (smRNAS), regulate developmental processes in animals and plants.
Investigating new materials with ultracold atoms
The investigation of complex materials such as high-temperature superconductors is problematic because of the presence of disorder and many competing interactions in real crystalline materials. "This makes it difficult to identify the role of specific interactions and, in particular, to decide whether repulsive interactions between electrons alone can explain high-temperature superconductivity," says Dr. Theodoulos Costi from the Institute of Solid State Research, Forschungszentrum Jülich, Germany.
Unlocking the mysteries of memory
Stop and think for a moment. What do you remember about your breakfast this morning? One part of your brain will recall the smell of coffee brewing, while another will remember your partner's smile while walking out the door. How does the brain weave together these fragments, and how does it bring them back to conscious life?
Past religious diversity and intolerance have profound impact on genetics of Iberian people
New research suggests that relatively recent events had a substantial impact on patterns of genetic diversity in the southwest region of Europe. The study, published by Cell Press on December 4th in the
American Journal of Human Genetics, shows that geographical patterns of ancestry appear to have been influenced by religious conversions of both Jews and Muslims in the Iberian Peninsula.
Top-up system has hidden costs that have not been accounted for
The "cost" of top-up payments to the NHS are not confined to the cost of the drug and require the NHS to make some long overdue changes or risk financial failure, argue two editorials published in
Clinical Oncology, by Elsevier.
Study supports new standard of treatment for women with advanced ovarian cancer
Results of a phase III, international randomized clinical trial demonstrate a new standard of care for treating advanced ovarian cancer that significantly reduces side-effects and post-operative deaths compared to the previously established treatment course. The study, presented at the 12th Biennial Meeting of the International Gynecologic Cancer Society (IGCS) in Bangkok in October, has a major impact on many countries where the new standard represents a more practical course of treatment.
Avalanches -- triggered from the valley
Everybody knows that skiers swishing down steep slopes can cause extensive slab avalanches. But there is a less well known phenomenon: A person skiing a gentle slope in the valley triggers a slab avalanche on a steeper slope, sometimes several hundred meters further uphill. This scenario doesn't seem to make sense – yet it claims human lives year after year.